Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant

By Isaka M.   Yasuda Y.   Taniguchi T.   Kozuka S.   Matano K.   Maeyama J.-i.   Morokuma K.   Ohkuma K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1165-1173

Elsevier

Access to resources Recommend Favorite

Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant

By Wu H.-Y.   Russell M.W.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 286-292

Elsevier

Access to resources Recommend Favorite

Mucosal binding compositions for generating mucosal immune response; Chlamydia, HIV virus, hepatitis B virus or enterotoxigenic Escherichia coli antigen and cholera toxin binding subunit fusion protein expression, for use as a recombinant vaccine

By Lebens M.   Holmgren J.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1299-1299

Elsevier

Access to resources Recommend Favorite

Intranasal or subcutaneous co-administration of recombinant cholera toxin B subunit stimulates only a slight or no level of the specific IgE response in mice to tetanus toxoid

By Isaka M.   Yasuda Y.   Kozuka S.   Taniguchi T.   Miura Y.   Matano K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 944-948

Elsevier

Access to resources Recommend Favorite

A comparison of natural and recombinant cholera toxin B subunit as stimulatory factors in intranasal immunization

By de Geus B.   Dol-Bosman M.   Scholten J.W.   Stok W.   Bianchi A.  

Vaccine, Vol. 15, Iss. 10, 1997-07 ,pp. : 1110-1113

Elsevier

Access to resources Recommend Favorite